Agiri Oluwagbemileke Yusuf 4
4 · Gevo, Inc. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Gevo, Inc.GEVO
Transactions
- Exercise/Conversion
Common Stock
2025-12-05$1.59/sh+36,446$57,949→ 312,550 total - Exercise/Conversion
Common Stock
2025-12-05$0.71/sh+31,958$22,690→ 344,508 total - Sale
Common Stock
2025-12-05$2.31/sh−73,284$169,183→ 271,224 total - Exercise/Conversion
Stock Option
2025-12-05+36,446→ 18,223 totalExercise: $1.59Exp: 2033-08-03→ Common Stock (36,446 underlying) - Exercise/Conversion
Stock Option
2025-12-05+31,958→ 63,917 totalExercise: $0.71Exp: 2034-05-21→ Common Stock (31,958 underlying)
Holdings
- 18,947.94(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.29 to $2.335 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Between September 4, 2025 and December 5, 2025, the reporting person disposed of 22.34 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated November 25, 2025.
- [F3]The option became exercisable in three equal annual installments beginning on August 3, 2024.
- [F4]The option became exercisable in three equal annual installments beginning on May 22, 2025.